Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)

Clinical trial NCT04973228 · COMPLETED

Trial details

NCT number: NCT04973228
Sponsor: Arcutis Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seborrheic Dermatitis

Start date: 2021-07-08
Primary completion: 2022-04-06
Enrollment: 457

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.